Stock HEMO HEMOGENYX PHARMACEUTICALS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Hemogenyx Pharmaceuticals Plc

Equities

HEMO

GB00BYX3WZ24

Market Closed - London S.E.
Other stock markets
 11:35:07 2024-05-15 EDT 		5-day change 1st Jan Change
1.56 GBX 0.00% Intraday chart for Hemogenyx Pharmaceuticals Plc +1.43% -32.17%
04-25 Hemogenyx Pharmaceuticals Plc Reports Earnings Results for the Full Year Ended December 31, 2023 CI
02-29 Hemogenyx Pharmaceuticals raises money for leukaemia treatment AN

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Fragrant Prosperity to buy Hi 55, Oscillate talks end
AN
Hemogenyx Pharmaceuticals Plc Announces Appointment of Stuart Tinch as Director of Quality
CI
Hemogenyx Pharmaceuticals plc Appoints Koen Van Besien as Medical Director
CI
Hemogenyx Pharmaceuticals plc Announces the Appointment of Dr. Alan E. Walts as Board Observer and Business Advisor
CI
Robin Campbell to Step Down as Non-Executive Director of Hemogenyx Pharmaceuticals Plc, Effective January 5, 2019
CI
Hemogenyx Pharmaceuticals plc Announces Executive Changes
CI
Hemogenyx Pharmaceuticals Plc Announces Board Changes
CI
Hemogenyx Pharmaceuticals Plc. Appoints H. Michael Shepard as Scientific Advisory Board
CI
Hemogenyx Pharmaceuticals Plc ("Hemogenyx" or the "Company"): LakePharma appointed as Service Provider for lead drug development
MW
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HEMO Stock
  4. News Hemogenyx Pharmaceuticals Plc
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW